Okay, let's tackle this question step by step. The question is about fatty acid synthesis and asks which statement is not true. First, I need to recall the key points of fatty acid synthesis. The core concept here is the process by which the body synthesizes fatty acids, primarily in the liver and adipose tissue. The main enzyme involved is acetyl-CoA carboxylase (ACC), which catalyzes the conversion of acetyl-CoA to malonyl-CoA, a crucial step in the pathway.

Now, the correct answer is probably an option that incorrectly describes this process. Let's think about common misconceptions. For example, fatty acid synthesis occurs in the cytosol, not the mitochondria. Also, NADPH is the primary reducing agent, not NADH. Another point is that the process uses acetyl-CoA, which is derived from carbohydrates via the citrate shuttle. The elongation of fatty acids beyond 16 carbons is done by a different enzyme system, perhaps the elongase, but that's part of the synthesis pathway.

Looking at the options, the incorrect statement might be something like "Fatty acid synthesis occurs in the mitochondria" (which would be wrong because it's in the cytosol) or "NADH is the reducing agent" (should be NADPH). Another possible error is that the process is inhibited by insulin, but actually, insulin promotes it. Alternatively, a statement that fatty acid synthesis is activated by high levels of citrate might be correct, so an option saying the opposite would be wrong.

Each distractor needs to be evaluated. For instance, if an option states that acetyl-CoA carboxylase is activated by palmitoyl-CoA, that's incorrect because palmitoyl-CoA is a feedback inhibitor. Alternatively, if an option mentions that the process requires ATP, that's correct since it's an energy-requiring pathway.

The clinical pearl here is to remember the key enzymes and their regulators. Acetyl-CoA carboxylase is a key regulatory enzyme, and its inhibition by biguanides like metformin is a high-yield point. Also, the role of NADPH in providing reducing equivalents is essential for the synthesis process. Another high-yield fact is the distinction between fatty acid synthesis and oxidation in terms of location and energy requirements.

**Core Concept**
Fatty acid synthesis occurs in the cytosol of liver and adipose cells, using acetyl-CoA derived from carbohydrates. Key steps include malonyl-CoA formation by acetyl-CoA carboxylase (ACC) and elongation via fatty acid synthase, requiring NADPH as a reducing agent.

**Why the Correct Answer is Right**
The incorrect statement is likely **Option D**: "Fatty acid synthesis occurs in the mitochondria." This is false because fatty acid synthesis happens in the **cytosol**, while mitochondrial acetyl-CoA must be transported via the citrate shuttle. The pathway relies on NADPH, not NADH, and is regulated by insulin and citrate. Mitochondria are the site of fatty acid oxidation (beta-oxidation), not synthesis.

**Why Each Wrong Option is Incorrect**
**Option A:** "Acetyl-CoA is the starting substrate" is correct. Acetyl-CoA is carboxylated to malonyl-CoA by ACC

✓ Correct Answer: B. Requires NADH